PE Ratio
65.60
₹1,270.30 -29.40 (-2.26%)
As on October 30, 2026
-7.45%
1 Y CAGR
38,094
CR
Market Cap
Company profile
Operating throughout India, Global Health Limited, known by its Medanta brand, stands as a prominent multi-specialty tertiary care provider. The company delivers a comprehensive suite of healthcare services, with particular expertise in cardiology, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplantation, as well as kidney and urology treatments. Established in 2004 and headquartered in Gurgaon, India, it operates a network of four hospitals strategically located in Gurugram, Indore, Ranchi, and Lucknow.
Price Chart
Fundamentals - Company Valuation
PB Ratio
0.034
Dividend Yield
0.037%
Sector PE
42.60
Sector ROE
11.70%
Sector Dividend Yield
0.46%
Financials
LIVE DATA FEED
Total Revenue (YTD)
₹44.1KCAGR 5-Year
+19.45%Peers & Comparison
SUNPHARMA
Sun Pharmaceutical Industries Ltd
Market cap: ₹4,41,477.63 Cr
DIVISLAB
Divi's Laboratories Ltd
Market cap: ₹2,41,576.41 Cr
TORNTPHARM
Torrent Pharmaceuticals Ltd
Market cap: ₹1,82,576.57 Cr
Missed the last rally? Don’t miss the next
Looking for AI-researched technical positive stocks?
Our AI-powered Analytical Portal finds the strongest technical positive stocks with actionable Buy & Sell opportunities.
Corporate Actions
Still Thinking? Not sure which stocks are right for you?
We help investors understand what to buy, when to buy, and why it makes sense for them.
customersupport@jarvisinvest.com
New Customers (Enquiry): +91 7208809638
Mon - Sat | 10:00 AM - 07:00 PM (Sunday Closed)
